Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin pseudogene (ENSG00000230080) is classified as a pseudogene based on genome annotation sources. It does not encode a functional protein and is not expressed as a typical gene product. Pseudogenes are DNA sequences resembling genes but are generally non-functional due to mutations, deletions, or lack of proper regulatory elements. This particular pseudogene shows high sequence homology to protein-coding actin genes but does not contribute to actin protein synthesis. It is not implicated in any biological pathways, diseases, or considered a drug target. Notably, the presence of many actin pseudogenes in the human genome complicates the use of actin (ACTB) as a housekeeping reference gene in molecular assays due to potential mis-priming and amplification artifacts[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin pseudogene.